We measured plasma homocyst(e)ine [H(e)] and other coronary risk factors in 266 patients with early coronary artery disease from 170 families in which two or more siblings were affected and in 168 unmatched controls. The mean H(e) concentration adjusted for significant correlates (serum creatinine, uric acid, and low-density lipoprotein cholesterol) was 12.0 zmol/L in proband cases compared with 10.1 j.mol/L in controls (P = 0.0001). Many (17.6%) of the proband cases had H(e) concentrations exceeding the 95th percentile for the controls (relative odds = 4.9, P <0.001 
to be about twice as common in cases with early CAD as in controls and is associated with increased concentrations of 11(e) (11). Genest et al. (12) examined H(e) in relatives of male CAD probands. Among the 71 probands, 28% had H(e) concentrations greater than the 90th percentile of normal controls, and 14% of the probands had at least one first-degree relative with H(e) concentrations similarly increased. Although significant spouse/spouse correlation in that study suggested that shared environment contributed to similar concentrations within families, segregation of high H(e) values was apparent in several families. However, no assessment of concurrent diet or plasma concentrations of vitamins was made in that study.
We have previously reported increased concentrations
of H(e) among a small series of male and female patients with early familial CAD (13) . The present study represents an analysis of a much larger group of early famil- 
Materials and Methods

Study Participants
Familial coronary probands were ascertained from two sources. About 75% were identified on computerized discharge records from area hospitals. Men 55 years and women 65 years who were living in Utah and had been discharged with a diagnosis of myocardial infarction (MI), percutaneous transluminal coronary angloplasty (PTCA), or coronary artery bypass surgery (CABG) were contacted by mail to determine whether they had another first-degree relative who had had a similarly early onset of CAD. Those who responded positively were probands with early familial CAD. After 2861 letters were sent, 61 patients were confirmed deceased and 223 had bad addresses and could not be contacted, leaving 2577 potential respondents. Of these, 1481 (5 7%) did not respond and no further contacts were made. Of the 1096 responders, 339 (3 1%) reported having an affected first-degree relative. The remainder either reported a negative family history (667) or could provide no information on their relatives. Of the 339 probands with a positive family history, the first 157 who could be scheduled were screened in the Cardiovascular Genetics Research clinics. We were able to recruit for screening >90% of those invited to our clinic. Other living, affected first-degree relatives were also screened. This study included only families with two or more siblings having early CAD (n = 128 families); 29 affected parent-offspring pairs were excluded. An additional 42 probands with early familial coronary disease were ascertained in a similar fashion from a populationbased registry of family history forms, which included health information completed as part of the high school curriculum in 50 northern Utah high schools (14, 15). In all, 266 early coronary cases in 170 sibships were included in this study. In 85 sibships, two or more affected living siblings were screened in our clinic.
Given our high recruitment rate (>90%), the current sample is probably quite representative of available families.
Although detailed characteristics of nonresponders to our initial letter are not available, we did compare demographic features of the participants with those of all others on the hospital discharge computer files who were sent initial letters. Age and sex distributions were not significantly different. However, significantly more nonparticipants were coded as having had acute MI (52%) as opposed to other ischemic heart diseases. Thus, the participants (36% with acute MI) probably represent individuals who had less severe CAD and survived long enough to participate in our study.
Control subjects were ascertained either from a random population sample of parents listed on the family history forms noted above (n = 58) or were spouses of hypertensive siblings who had participated in previous studies in our clinic (n = 108) (16). Tests for comparability of the two control groups showed no significant differences for any cardiovascular risk factor or H(e), except for a slightly higher plasma total cholesterol among the spouses of hypertensive siblings (P = 0.05).
Because use of a slightly higher serum cholesterol concentration would only provide a more conservative comparison with the early familial coronary cases, we combined the two control groups for all further analyses. (17) . Increased randomness in H(e) measurements due to the extraction step would tend to obscure any real relationships that may exist. However, because the method was the same for both cases and controls, no bias is introduced.
We assessed the accuracy of our assay by comparing 29 Plasma HDL cholesterol was lower among the cases. 11(e) was significantly higher in the cases than in the controls. Other potential determinants of H(e) also showed differences between cases and controls, most notably serum concentrations of creatinine, uric acid, and albumin.
Measured concentrations of plasma LDL cholesterol did not differ between the cases and the controls, probably because of treatment of 52% of the cases for high cholesterol (34% were taking drugs). Only 6% of the controls were on a diet and none was taking lipid-lowering medication.
Percentiles of H(e) among the control group are given in Table 3 . Among the male controls from this study (n were made within age-and sex-specific groups (Fig. 2) . Despite the striking differences in H(e) between cases and controls, the question arises, would the differences remain after adjustment for potentially confounding covariates? We performed multiple stepwise regression with 11(e) as the dependent variable and all the variables in Tables 1 and 2 as potential independent variables. Both forward and backward stepping models were tested with similar results. Table 4 shows the results of the forward multiple stepwise linear regression. In these analyses, all unrelated cases and controls were considered together, regardless of case status.
Age,years
Body mass index, kg/rn2 Variables testedincluded: age, gender(0 = female, 1 = male), body mass index, cigarette smoking (never = 0, former = 1, current = 2), hypertension (no = 0, yes = 1), diabetes (no = 0, yes = 1), taking iipid-iowering medication (no = 0, yes = 1), systolic blood pressure, diastolic blood pressure, and plasma triglycerides, HDLcholesterol, measuredLDLcholesterol,glucose,uric acid,creatinine, and total protein (all in mg/dL). Unrelatedfamilial coronary cases (n = 170) and controls (n = 168)were included together. Creatinine was the strongest and most consistent correlate of 11(e). Furthermore, creatinine explained sex differences within the case and control groups (Fig. 3) model tested included serum concentrations of creatinine, uric acid, and measured LDL cholesterol, as well as cigarette smoking and age. These were the only variables that were selected at P <0.05 in both the forward and backward stepping models. We also tested the interaction terms of these variables with case status, eliminating nonsignificant interaction terms stepwise on the basis of their F values. None of the interaction terms remained significant, suggesting that effects of the selected variables did not differ between the case and control groups. Age and cigarette smoking status were also not significantly related to log-transformed 11(e) concentrations in the analysis of covariance. In the final model, besides case status, only serum creatinine, uric acid, and measured LDL cholesterol remained significant (P <0.0001, P <0.0001, and P = 0.004, respectively).
The results of this analysis of covariance are shown in Fig. 4 . The difference between cases and controls for adjusted 11(e), i.e., determined from the difference of the antilogs, was 2.0 mol/L (P = 0.0001). When we repeated these analyses, restricting the evaluation to subjects of ages 35-70 years so that cases and controls compared would have the same age range (163 cases, 160 controls), we saw no effect on the 11(e) difference between cases and controls or its statistical significance.
Familial H(e) and Plasma Vitamin Concentrations
To assess the role that nutrient intake may have played, we determined the plasma concentrations of vitamins B6, B12, and folate in all cases and their affected siblings. There were significant inverse correlations between the concentrations of each vitamin and of 11(e) in plasma. In addition, the vitamin concentrations were positively correlated with each other (Table 5) . Accordingly, we performed step-wise regression among all cases and their affected siblings, using log-transformed H(e) as the dependent variable and the above-named vitamins and the previously considered potential covariates as independent variables. Again, creatinine was the first independent variable to enter (F = 42.7, P <0.0001).
Plasma folate concentration was next (F = 20.6, P <0.0001), followed by vitamin B12 (F = 11.6, P = 0.0008), uric acid (F = 10.9, P = 0.001), gender (F = 9.6, P = 0.002), and total protein (F = 8.1, P = 0.005). Vitamin B6 concentrations did not add significantly to the model once folate and vitamin B12 were included.
To further evaluate H(e) concentrations in cases and controls by utilizing all available cases, we used a general linear model with intraclass correlation. This model accounts for similarities between siblings (nonindependent observations) as well as contributions from the above-named covariates. The regression coefficient for case status without adjusting for vitamin concentrations was 0.161 (SE 0.030, P <0.00001).
Taking the antilog of the regression coefficient for case status provides an estimate of the adjusted ratio of 11(e) in cases to 11(e) in controls (the slope of the regression line). If the control mean is taken as 10 mo1IL, the expected mean This provides an estimate of the prevalence of sporadic high concentrations of 11(e) among early familial CAD cases. The presence of two or more case siblings having increased H(e) in a given family may serve to diagnose familial hyperhomocyst(e)inemia leading to early familial CAD. Initially, we used as cutoffs the sex-specific 90th percentiles derived from the control group. When plasma samples were available for two or more affected siblings in a family (85 families), we found 8 (9.4%) families with two or more cases having 11(e) greater than the 90th percentile (1% expected). In 3 (3.6%) of these 85 families two or more siblings had H(e) greater than the control 95th percentile (0.25% expected). After adjustment for vitamin content (folate, vitamin B12, and vitamin B6), concordant H(e) concentrations exceeding the control 90th percentile were found in 13 (15%) of the families, and 3 (3.6%) families still showed concordant concentrations greater than the 95th percentile. Vitamin content below the reference range was seen in only three cases: two with low vitamin B6 values (8. 
DiscussIon
This is the first study to examine H(e) concentrations in a large number of families ascertained by the presence of multiple siblings with early CAD. It is also the first study to report clear evidence for bimodality in the 11(e) distribution from such cases. This bimodality was present both before and after controlling for intake of vitamins B6, B12, and folate. Finding 9-12% of 85 families with two or more affected early coronary cases having increased concentrations of 11(e) corresponded remarkably well with the results of commingling analysis, which found -8% of coronary cases in the higher H(e) mode after adjustment for plasma vitamin concentrations. These results suggest that a major gene influencing 11(e) concentrations may be present in -10% of early familial CAD cases. The absence of the higher 11(e) mode in controls further supports the relevance of high H(e) in the pathogenesis of early CAD. Here we briefly summarize some of these findings.
Chronic infusion of homocysteine into baboons has resulted in extensive endothelial desquamation and a reduction in platelet survival (25). These findings were thought to be a result of direct cytotoxicity of homocysteine and its thiolactone, largely through the actions of copper-catalyzed hydrogen peroxide generated by autooxidation of the SH group (26, 27 for fibrin. Such a complex may inhibit plasmin and favor thrombosis (35) . Thus, multiple mechanisms may contribute to the thrombotic diathesis associated with increased H(e).
The reaction of thiol compounds to form hydrogen peroxide involves generation of free radical intermediates. Increased concentrations of 11(e) have therefore been hypothesized to lead to increased production of oxidized lipoproteins, which may promote foam cell formation by way of the scavenger receptor (36, 37). This concept has recently been challenged, however, because no increases in cholesterol hydroperoxide were found in HDL of patients with homozygous cystathionine f3-synthase deficiency (38) .
There were some limitations in our analyses. The age and sex distributions were considerably different between cases and controls. The older average ages of the cases probably contributed importantly to the much higher prevalence of hypertension and diabetes in this group than in the controls. However, after adjustment for serum creatinine, H(e) concentrations were not related to age or gender. Furthermore, when examined within case-and gender-specific groups, age did not correlate significantly with logarithmically transformed H(e) concentrations (data not shown). Finally, none of the results were materially affected by constraining the age range of the cases and the controls to be entirely overlapping.
The paucity of women among the early familial coronary cases was somewhat surprising, given our use of an older age cut-point to allow for the well-known difference in coronary incidence rates between men and women. Possibly, women with early familial coronary disease did not survive as frequently as their male counterparts and thus were not available for screening in this study.
However, despite the excess of male cases, sex differences could not explain the H(e) discrepancy between cases and controls. Serum creatinine concentration was clearly the strongest covariate of H(e) and explained sex differences within the case and control groups (see Fig. 1 ). Case-control differences in H(e) were still highly significant after adjustment for relevant covariates. Furthermore, sex-and age-specific differences between cases and controls were highly significant (Fig. 2) . In addition, a marked excess of high H(e) values was seen among cases (relative odds, 4.9), exceeding the sex-specific 95th percentile derived from controls (P <0.001).
Other studies have noted a fairly strong negative correlation between vitamin intake or concentrations in plasma (especially vitamins B6, B12, and folate) and H(e) concentrations among free-living persons (8) (9) (10) 39 The presence of bimodality, even after correcting for
